<article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><front><journal-meta><journal-id journal-id-type="nlm-ta">J Pain Res</journal-id><journal-id journal-id-type="iso-abbrev">J Pain Res</journal-id><journal-id journal-id-type="publisher-id">Journal of Pain Research</journal-id><journal-title-group><journal-title>Journal of Pain Research</journal-title></journal-title-group><issn pub-type="epub">1178-7090</issn><publisher><publisher-name>Dove Medical Press</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">27462175</article-id><article-id pub-id-type="pmc">4940009</article-id><article-id pub-id-type="doi">10.2147/JPR.S106576</article-id><article-id pub-id-type="publisher-id">jpr-9-503</article-id><article-categories><subj-group subj-group-type="heading"><subject>Clinical Trial Report</subject></subj-group></article-categories><title-group><article-title>Effects of low-dose ketamine on succinylcholine-induced postoperative myalgia in outpatient surgeries: a randomized, double-blind study</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Nasseri</surname><given-names>Karim</given-names></name><xref ref-type="aff" rid="af1-jpr-9-503">1</xref><xref ref-type="corresp" rid="c1-jpr-9-503"></xref></contrib><contrib contrib-type="author"><name><surname>Arvien</surname><given-names>Sanaz</given-names></name><xref ref-type="aff" rid="af2-jpr-9-503">2</xref></contrib></contrib-group><aff id="af1-jpr-9-503"><label>1</label>Department of Anesthesia and Intensive Care, Social Determinants of Health Research Center</aff><aff id="af2-jpr-9-503"><label>2</label>Student Research Committee, Kurdistan University of Medical Sciences, Sanandaj, Iran</aff><author-notes><corresp id="c1-jpr-9-503">Correspondence: Karim Nasseri, Department of Anesthesia and Intensive Care, Medical School, Kurdistan University of Medical Sciences, Pasdaran Street, 6617713446, Sanandaj, Iran, Tel +98 87 3366 0733, Fax +98 871 3323 3600, Email <email>Nasseri_k@muk.ac.ir</email></corresp></author-notes><pub-date pub-type="collection"><year>2016</year></pub-date><pub-date pub-type="epub"><day>06</day><month>7</month><year>2016</year></pub-date><volume>9</volume><fpage>503</fpage><lpage>508</lpage><permissions><copyright-statement>© 2016 Nasseri and Arvien. This work is published and licensed by Dove Medical Press Limited</copyright-statement><copyright-year>2016</copyright-year><license><license-p>The full terms of this license are available at <ext-link ext-link-type="uri" xlink:href="https://www.dovepress.com/terms.php">https://www.dovepress.com/terms.php</ext-link> and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc/3.0/">http://creativecommons.org/licenses/by-nc/3.0/</ext-link>). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.</license-p></license></permissions><abstract><sec><title><offsets xml_i="3271" xml_f="3280" txt_i="11" txt_f="20">Objective</offsets></title><p><offsets xml_i="3291" xml_f="3608" txt_i="21" txt_f="338">Despite the many complications of succinylcholine, it is still widely used as a superior muscle relaxant for rapid sequence induction. One of these complications is postoperative myalgia (POM). The aim of this study was to investigate the prophylactic effect of low-dose ketamine on the incidence and severity of POM.</offsets></p></sec><sec><title><offsets xml_i="3630" xml_f="3651" txt_i="340" txt_f="361">Materials and methods</offsets></title><p><offsets xml_i="3662" xml_f="4439" txt_i="362" txt_f="1139">In this double-blind clinical study, a total of 148 patients scheduled for general anesthesia were randomly divided into two equal groups. Initially, in Group K, 0.5 mg/kg of ketamine was injected intravenously, whereas in Group N, the same volume (5 mL) of normal saline was injected. Thereafter, anesthesia was induced in all patients, by injecting 1.5 mg/kg of fentanyl and 2 mg/kg of propofol intravenously. Following the loss of eyelid reflex, 1.5 mg/kg of succinylcholine was injected intravenously as a muscle relaxant and then the patients were intubated. POM was defined as a pain with no surgical interferences, and its intensity was graded based on a four-point scale. The incidence and severity of myalgia were assessed by a blinded observer 24 hours after surgery.</offsets></p></sec><sec><title><offsets xml_i="4461" xml_f="4468" txt_i="1141" txt_f="1148">Results</offsets></title><p><offsets xml_i="4479" xml_f="4615" txt_i="1149" txt_f="1285">In terms of demographic data, the results of this study showed that there is no significant difference between patients in both groups (</offsets><italic><offsets xml_i="4623" xml_f="4624" txt_i="1285" txt_f="1286">P</offsets></italic><offsets xml_i="4633" xml_f="4737" txt_i="1286" txt_f="1387">&gt;0.05). Overall, the incidence of POM in Group K was significantly less, when compared with Group N (</offsets><italic><offsets xml_i="4745" xml_f="4746" txt_i="1387" txt_f="1388">P</offsets></italic><offsets xml_i="4755" xml_f="4948" txt_i="1388" txt_f="1578">&lt;0.05), but both groups were comparable based on the grade 2 of POM. After the induction of anesthesia, the systolic and diastolic blood pressure values were found to reduce in both groups (</offsets><italic><offsets xml_i="4956" xml_f="4957" txt_i="1578" txt_f="1579">P</offsets></italic><offsets xml_i="4966" xml_f="5121" txt_i="1579" txt_f="1731">&lt;0.05). However, the changes were somehow similar, and repeated measures of variance analysis showed no significant difference in the two study groups (</offsets><italic><offsets xml_i="5129" xml_f="5130" txt_i="1731" txt_f="1732">P</offsets></italic><offsets xml_i="5139" xml_f="5149" txt_i="1732" txt_f="1739">&gt;0.05).</offsets></p></sec><sec><title><offsets xml_i="5171" xml_f="5181" txt_i="1741" txt_f="1751">Conclusion</offsets></title><p><offsets xml_i="5192" xml_f="5334" txt_i="1752" txt_f="1894">The addition of 0.5 mg/kg of ketamine to propofol for the induction of anesthesia can be effective in reducing the incidence of low-grade POM.</offsets></p></sec></abstract><kwd-group><title>Keywords</title><kwd>ketamine</kwd><kwd>succinylcholine</kwd><kwd>myalgia</kwd><kwd>complication</kwd><kwd>propofol</kwd></kwd-group></article-meta></front><body><sec sec-type="intro"><title><offsets xml_i="5564" xml_f="5576" txt_i="1903" txt_f="1915">Introduction</offsets></title><p><offsets xml_i="5587" xml_f="5742" txt_i="1916" txt_f="2068">For &gt;60 years, succinylcholine is still being administered as a selective relaxant for rapid sequence intubation by anesthesiologists in many countries.</offsets><xref rid="b1-jpr-9-503" ref-type="bibr"><offsets xml_i="5783" xml_f="5784" txt_i="2068" txt_f="2069">1</offsets></xref><offsets xml_i="5791" xml_f="5958" txt_i="2069" txt_f="2236"> It has been shown to possess unique features such as low cost, fast-acting, short half-life, safe metabolites, and causing excellent muscle relaxation for intubation;</offsets><xref rid="b2-jpr-9-503" ref-type="bibr"><offsets xml_i="5999" xml_f="6000" txt_i="2236" txt_f="2237">2</offsets></xref><offsets xml_i="6007" xml_f="6238" txt_i="2237" txt_f="2468"> however, it has many side effects as well. Postoperative myalgia (POM), with an incidence rate of ~41%–92%, is one of the most common side effects of this drug and can take several days to cause significant discomfort in patients.</offsets><xref rid="b3-jpr-9-503" ref-type="bibr"><offsets xml_i="6279" xml_f="6280" txt_i="2468" txt_f="2469">3</offsets></xref><offsets xml_i="6287" xml_f="6427" txt_i="2469" txt_f="2609"> However, its effect is felt more in the throat, neck, shoulder, and abdominal muscles and is common among patients with outpatient surgery.</offsets><xref rid="b4-jpr-9-503" ref-type="bibr"><offsets xml_i="6468" xml_f="6469" txt_i="2609" txt_f="2610">4</offsets></xref><offsets xml_i="6476" xml_f="6827" txt_i="2610" txt_f="2961"> Due to its unknown real context of pathogenesis and in an effort to reduce the incidence and severity of succinylcholine-induced myalgia, various medications including nondepolarizing muscle relaxants, benzodiazepines, magnesium sulfate, opioids, gabapentin, and nonsteroidal anti-inflammatory drugs have been tested, with varying degrees of success.</offsets><xref rid="b5-jpr-9-503" ref-type="bibr"><offsets xml_i="6868" xml_f="6869" txt_i="2961" txt_f="2962">5</offsets></xref><offsets xml_i="6876" xml_f="6877" txt_i="2962" txt_f="2963">,</offsets><xref rid="b6-jpr-9-503" ref-type="bibr"><offsets xml_i="6918" xml_f="6919" txt_i="2963" txt_f="2964">6</offsets></xref></p><p><offsets xml_i="6933" xml_f="6948" txt_i="2965" txt_f="2980">Ketamine is an </offsets><italic><offsets xml_i="6956" xml_f="6957" txt_i="2980" txt_f="2981">N</offsets></italic><offsets xml_i="6966" xml_f="7202" txt_i="2981" txt_f="3217">-methyl-d-aspartate (NMDA) receptor antagonist with excellent analgesic activity, and at subanesthetic doses it is capable of preventing central sensitization, hyperalgesia, drug resistance creation, and reduction of postoperative pain.</offsets><xref rid="b7-jpr-9-503" ref-type="bibr"><offsets xml_i="7243" xml_f="7244" txt_i="3217" txt_f="3218">7</offsets></xref><offsets xml_i="7251" xml_f="7604" txt_i="3218" txt_f="3571"> Although, ketamine administration could produce unpleasant psychogenic complications, no disagreeable effects have been recorded in patients who received a low dose of ketamine. The effects of ketamine on postelectroconvulsive therapy (ECT) myalgia have been studied earlier, and the results showed that ketamine could not prevent this type of myalgia.</offsets><xref rid="b8-jpr-9-503" ref-type="bibr"><offsets xml_i="7645" xml_f="7646" txt_i="3571" txt_f="3572">8</offsets></xref></p><p><offsets xml_i="7660" xml_f="7995" txt_i="3573" txt_f="3908">To the best of our knowledge, the effect of ketamine on the prevention of POM is yet to be determined. Therefore, in this randomized, double-blind study, the prophylactic effect of low-dose ketamine on the incidence and severity of myalgia caused by succinylcholine injection in patients undergoing outpatient surgery was investigated.</offsets></p></sec><sec sec-type="materials|methods"><title><offsets xml_i="8046" xml_f="8067" txt_i="3910" txt_f="3931">Materials and methods</offsets></title><p><offsets xml_i="8078" xml_f="8703" txt_i="3932" txt_f="4557">This study was approved by the Ethics Committee of Kurdistan University of Medical Sciences and was registered in the Iranian Registry of Clinical Trials (IRCT2014062412789N5). A complete description of the study was also presented to each participant, and written informed consent was obtained. The sample size was calculated based on the assumption that the incidence of POM in outpatient cases is ~70%, and intervention that can cause 25% reduction in incidence of POM will be interesting. To consider this difference and type I error equal to 5% and 90% power of the study, 72 patients were required to be in each group (</offsets><italic><offsets xml_i="8711" xml_f="8712" txt_i="4557" txt_f="4558">α</offsets></italic><offsets xml_i="8721" xml_f="8731" txt_i="4558" txt_f="4568">=0.05 and </offsets><italic><offsets xml_i="8739" xml_f="8740" txt_i="4568" txt_f="4569">β</offsets></italic><offsets xml_i="8749" xml_f="9391" txt_i="4569" txt_f="5211">=90%), but in order to avoid possible loss of samples during the study, the number of patients in each group was increased to 74. Thus, 148 patients, who were scheduled for outpatient surgery under general anesthesia, belonging to the American Society of Anesthesiologists physical status I and II within the age of 18–70 years, were included in this double-blind randomized clinical trial. Patients with a history of allergy to medications; substance abuse; malignant hyperthermia; myopathy; cardiovascular, liver, and advanced kidney diseases; and the risk of difficult intubation based on physical examination were excluded from the study.</offsets></p><p><offsets xml_i="9398" xml_f="9569" txt_i="5212" txt_f="5383">Before surgery, patients were evaluated by the anesthesiologists. The study protocol and evaluation of myalgia based on Kararmaz’s criteria were described to the patients.</offsets><xref rid="b4-jpr-9-503" ref-type="bibr"><offsets xml_i="9610" xml_f="9611" txt_i="5383" txt_f="5384">4</offsets></xref><offsets xml_i="9618" xml_f="9789" txt_i="5384" txt_f="5555"> Based on a computer-generated random sequence, the 148 patients were enrolled into one of the two groups (ketamine or saline). The patients did not receive premedication.</offsets></p><p><offsets xml_i="9796" xml_f="10006" txt_i="5556" txt_f="5766">In the operating room, standard monitoring of the noninvasive blood pressure, electrocardiogram, heart rate, and pulse oximetry was done, and the preliminary values were recorded. Thereafter, a venous cannula (</offsets><italic><offsets xml_i="10014" xml_f="10015" txt_i="5766" txt_f="5767">G</offsets></italic><offsets xml_i="10024" xml_f="10998" txt_i="5767" txt_f="6741">=18) was placed on the dorsum of a patient’s hand. Before the induction of anesthesia in patients of Group K, 0.5 mg/kg of ketamine (a 5 mL volume was reached by adding distilled water) was injected intravenously and 5 mL of normal saline was injected intravenously slowly into patients in Group N. Drugs were prepared in 5 mL syringes by an anesthesia nurse who was unaware of the grouping. After injecting the study drugs, 1.5 mg/kg of fentanyl was injected intravenously within 60 seconds and subsequently 2 mg/kg of propofol was administered intravenously within 30 seconds for the induction of anesthesia. Following the loss of eyelid reflex, 1.5 mg/kg of succinylcholine was injected intravenously and patients were ventilated using bag and mask and with 100% oxygen. After fasciculation, the values of heart rate and blood pressure were measured and recorded, and tracheal intubation was performed. The maintenance of anesthesia continued using a mixture of oxygen, N</offsets><sub><offsets xml_i="11003" xml_f="11004" txt_i="6741" txt_f="6742">2</offsets></sub><offsets xml_i="11010" xml_f="11901" txt_i="6742" txt_f="7633">O (40/60), and isoflurane 1 MAC. After 5 minutes of tracheal intubation, the values of heart rate and blood pressure were obtained and recorded again. For maintenance of muscle relaxation, 0.2 mg/kg of atracurium was used as suggested by the surgeon. At the end of the surgery, muscle relaxation was reversed using neostigmine and atropine. After the desired spontaneous ventilation, the patients were extubated. The patients were transferred to the recovery room and complications, if any, were recorded during recovery. After meeting the discharge criteria, the patients were discharged to be taken home and cared for by a responsible adult. The incidence and severity of myalgia in the patients were determined 24 hours after surgery by a medical student who was unaware of the grouping. Myalgia is defined as “a pain with no surgical interference” and is graded based on Kararmaz et al’s</offsets><xref rid="b4-jpr-9-503" ref-type="bibr"><offsets xml_i="11942" xml_f="11943" txt_i="7633" txt_f="7634">4</offsets></xref><offsets xml_i="11950" xml_f="12207" txt_i="7634" txt_f="7891"> four-point scale as follows: 0= no muscle pain, 1= muscle stiffness limited to one area of the body, 2= muscle pain or stiffness noticed spontaneously by a patient who requires analgesics, and 3= incapacitating generalized, severe muscle stiffness or pain.</offsets></p><p><offsets xml_i="12214" xml_f="12492" txt_i="7892" txt_f="8170">Statistical analysis was conducted using SPSS Version 12.0 software (IBM Corporation, Armonk, NY). The comparison profile of the patients was performed using the analysis of variance test. The incidence and severity of myalgia were compared using the chi-square and independent </offsets><italic><offsets xml_i="12500" xml_f="12501" txt_i="8170" txt_f="8171">t</offsets></italic><offsets xml_i="12510" xml_f="12531" txt_i="8171" txt_f="8192">-tests. The value of </offsets><italic><offsets xml_i="12539" xml_f="12540" txt_i="8192" txt_f="8193">P</offsets></italic><offsets xml_i="12549" xml_f="12599" txt_i="8193" txt_f="8240">&lt;0.05 was considered statistically significant.</offsets></p></sec><sec sec-type="results"><title><offsets xml_i="12640" xml_f="12647" txt_i="8242" txt_f="8249">Results</offsets></title><p><offsets xml_i="12658" xml_f="13317" txt_i="8250" txt_f="8909">In this study, a total of 207 patients were scheduled for outpatient surgery from July 2013 to August 2014. Of them, 29 patients could not meet the entry criteria. Twenty-seven patients had no willingness to participate in the study, and the surgery of three patients was canceled. The remaining 148 patients were randomly assigned into two groups. Two patients in Group N due to nausea, vomiting, and pain and one patient in Group K due to arrhythmia were turned from outpatient to inpatient. Two persons from Group K did not cooperate with the evaluation of POM. The data associated with the 72 patients in Group N and 71 patients in Group K were analyzed (</offsets><xref ref-type="fig" rid="f1-jpr-9-503"><offsets xml_i="13357" xml_f="13365" txt_i="8909" txt_f="8917">Figure 1</offsets></xref><offsets xml_i="13372" xml_f="13374" txt_i="8917" txt_f="8919">).</offsets></p><p><offsets xml_i="13381" xml_f="13486" txt_i="8920" txt_f="9025">There were no significant differences in terms of age, sex, and duration of surgery between both groups (</offsets><xref ref-type="table" rid="t1-jpr-9-503"><offsets xml_i="13528" xml_f="13535" txt_i="9025" txt_f="9032">Table 1</offsets></xref><offsets xml_i="13542" xml_f="13668" txt_i="9032" txt_f="9158">). In Group K, 13 (18.1%) out of the 71 patients had myalgia, whereas 36 (50%) out of the 72 patients had myalgia in Group N (</offsets><italic><offsets xml_i="13676" xml_f="13677" txt_i="9158" txt_f="9159">P</offsets></italic><offsets xml_i="13686" xml_f="13794" txt_i="9159" txt_f="9267">=0.001). Grade 1 POM was lower in Group K when compared with Group N (nine in Group K versus 33 in Group N; </offsets><italic><offsets xml_i="13802" xml_f="13803" txt_i="9267" txt_f="9268">P</offsets></italic><offsets xml_i="13812" xml_f="13910" txt_i="9268" txt_f="9363">&lt;0.001), whereas the incidence of grade 2 POM was comparable among patients of the two groups (</offsets><xref ref-type="table" rid="t2-jpr-9-503"><offsets xml_i="13952" xml_f="13959" txt_i="9363" txt_f="9370">Table 2</offsets></xref><offsets xml_i="13966" xml_f="14187" txt_i="9370" txt_f="9591">). The baseline values of systolic and diastolic blood pressure and heart rate in both groups were similar. After the induction of anesthesia, the values of systolic and diastolic blood pressure decreased in both groups (</offsets><italic><offsets xml_i="14195" xml_f="14196" txt_i="9591" txt_f="9592">P</offsets></italic><offsets xml_i="14205" xml_f="14371" txt_i="9592" txt_f="9755">&lt;0.05). However, these changes were somehow similar in the two groups, and repeated measures of variance analysis showed no significant difference in both groups (</offsets><italic><offsets xml_i="14379" xml_f="14380" txt_i="9755" txt_f="9756">P</offsets></italic><offsets xml_i="14389" xml_f="14585" txt_i="9756" txt_f="9949">&gt;0.05). Changes in heart rate after induction and intubation between the two groups were compared and repeated measures of variance analysis showed no significant difference in the two groups (</offsets><italic><offsets xml_i="14593" xml_f="14594" txt_i="9949" txt_f="9950">P</offsets></italic><offsets xml_i="14603" xml_f="14613" txt_i="9950" txt_f="9957">&gt;0.05; </offsets><xref ref-type="table" rid="t3-jpr-9-503"><offsets xml_i="14655" xml_f="14662" txt_i="9957" txt_f="9964">Table 3</offsets></xref><offsets xml_i="14669" xml_f="14671" txt_i="9964" txt_f="9966">).</offsets></p></sec><sec sec-type="discussion"><title><offsets xml_i="14715" xml_f="14725" txt_i="9968" txt_f="9978">Discussion</offsets></title><p><offsets xml_i="14736" xml_f="14854" txt_i="9979" txt_f="10097">The results of this study showed that ketamine significantly reduced the incidence of succinylcholine-induced myalgia.</offsets></p><p><offsets xml_i="14861" xml_f="15084" txt_i="10098" txt_f="10321">Succinylcholine is a muscle relaxant that is commonly used due to deep neuromuscular blocks for intubation in patients undergoing ambulatory anesthesia, but associated myalgia has been shown to occur in 41%–92% of patients.</offsets><xref rid="b9-jpr-9-503" ref-type="bibr"><offsets xml_i="15125" xml_f="15126" txt_i="10321" txt_f="10322">9</offsets></xref><offsets xml_i="15133" xml_f="15134" txt_i="10322" txt_f="10323">,</offsets><xref rid="b10-jpr-9-503" ref-type="bibr"><offsets xml_i="15176" xml_f="15178" txt_i="10323" txt_f="10325">10</offsets></xref><offsets xml_i="15185" xml_f="15480" txt_i="10325" txt_f="10620"> Since ambulation increases the possibility of myalgia and its intensity, ambulatory patients are suitable for investigating this complication. Therefore, this group of patients was chosen for the study. Myalgia is most prevalent following the use of succinylcholine in the first day of surgery.</offsets><xref rid="b11-jpr-9-503" ref-type="bibr"><offsets xml_i="15522" xml_f="15524" txt_i="10620" txt_f="10622">11</offsets></xref><offsets xml_i="15531" xml_f="15700" txt_i="10622" txt_f="10791"> As shown in a study, 92% of patients reported myalgia in the first 24 hours of study and the incidence of myalgia did not differ at 24 hours and 48 hours after surgery.</offsets><xref rid="b8-jpr-9-503" ref-type="bibr"><offsets xml_i="15741" xml_f="15742" txt_i="10791" txt_f="10792">8</offsets></xref><offsets xml_i="15749" xml_f="15828" txt_i="10792" txt_f="10871"> In this study, myalgia was evaluated only in the first 24 hours after surgery.</offsets></p><p><offsets xml_i="15835" xml_f="15944" txt_i="10872" txt_f="10981">It seems that the intrafusal contraction of muscle fibers caused damage to spindles and subsequently myalgia.</offsets><xref rid="b12-jpr-9-503" ref-type="bibr"><offsets xml_i="15986" xml_f="15988" txt_i="10981" txt_f="10983">12</offsets></xref><offsets xml_i="15995" xml_f="16250" txt_i="10983" txt_f="11238"> In vitro studies have shown that active, excessive, and continuous muscle contractions increase the uptake of calcium, activation of phospholipase A2, arachidonic acid, and prostaglandins production, thereby increasing the risk of muscle damage and pain.</offsets><xref rid="b13-jpr-9-503" ref-type="bibr"><offsets xml_i="16292" xml_f="16294" txt_i="11238" txt_f="11240">13</offsets></xref><offsets xml_i="16301" xml_f="16564" txt_i="11240" txt_f="11503"> The results of this study showed that 50% of the patients in Group N experienced myalgia after anesthesia was induced with propofol. In a meta-analysis, the average incidence of myalgia in the first 24 hours with thiopental was 49.2% and with propofol was 65.4%.</offsets><xref rid="b14-jpr-9-503" ref-type="bibr"><offsets xml_i="16606" xml_f="16608" txt_i="11503" txt_f="11505">14</offsets></xref><offsets xml_i="16615" xml_f="16814" txt_i="11505" txt_f="11704"> The incidence of myalgia in the present study was slightly lower when compared with the aforementioned meta-analysis. It appears that participants in this study belonged to low-level POM in general.</offsets></p><p><offsets xml_i="16821" xml_f="17115" txt_i="11705" txt_f="11999">Ketamine creates a complex combination of both antinociceptive and pronociceptive actions. In fact, based on the mechanisms of analgesia with a direct receptor, the analgesic effect of ketamine is associated with the plasma levels of drugs and pain reduces with subanesthetic doses of ketamine.</offsets><xref rid="b15-jpr-9-503" ref-type="bibr"><offsets xml_i="17157" xml_f="17159" txt_i="11999" txt_f="12001">15</offsets></xref><offsets xml_i="17166" xml_f="17167" txt_i="12001" txt_f="12002">,</offsets><xref rid="b16-jpr-9-503" ref-type="bibr"><offsets xml_i="17209" xml_f="17211" txt_i="12002" txt_f="12004">16</offsets></xref><offsets xml_i="17218" xml_f="17423" txt_i="12004" txt_f="12209"> In general, it seems that the NMDA receptor plays an important role in the pathophysiology of pain, and the Supra spinal block of the NR2B NMDA subunit by ketamine has an important antinociceptive effect.</offsets><xref rid="b17-jpr-9-503" ref-type="bibr"><offsets xml_i="17465" xml_f="17467" txt_i="12209" txt_f="12211">17</offsets></xref><offsets xml_i="17474" xml_f="17803" txt_i="12211" txt_f="12540"> Recent studies have shown the role of NMDA receptors in facilitating the process of pain in the central nervous system, this receptor is also responsible for central sensitization and windup phenomenon. The administration of NMDA receptor antagonists prevents the development of sensitization, hyperalgesia, and drug resistance.</offsets><xref rid="b18-jpr-9-503" ref-type="bibr"><offsets xml_i="17845" xml_f="17847" txt_i="12540" txt_f="12542">18</offsets></xref><offsets xml_i="17854" xml_f="17961" txt_i="12542" txt_f="12649"> Ketamine is an antagonist of this receptor and has excellent analgesic activity at doses under anesthesia.</offsets><xref rid="b19-jpr-9-503" ref-type="bibr"><offsets xml_i="18003" xml_f="18005" txt_i="12649" txt_f="12651">19</offsets></xref><offsets xml_i="18012" xml_f="18239" txt_i="12651" txt_f="12878"> It strengthens the performance of mu and kappa opioid receptors and also has direct effects on the delta opioid receptor. As such, ketamine certainly modulates the response of opioid receptors and reduces tolerance to opioids.</offsets><xref rid="b20-jpr-9-503" ref-type="bibr"><offsets xml_i="18281" xml_f="18283" txt_i="12878" txt_f="12880">20</offsets></xref><offsets xml_i="18290" xml_f="18452" txt_i="12880" txt_f="13042"> It also strengthens the endogenesis of antinociceptive systems, in part, by its aminergic (serotonergic and noradrenergic) activation and inhibition of reuptake.</offsets><xref rid="b21-jpr-9-503" ref-type="bibr"><offsets xml_i="18494" xml_f="18496" txt_i="13042" txt_f="13044">21</offsets></xref><offsets xml_i="18503" xml_f="18598" txt_i="13044" txt_f="13139"> It inhibits the synthesis of nitric oxide, which probably contributed to the analgesic effect.</offsets><xref rid="b22-jpr-9-503" ref-type="bibr"><offsets xml_i="18640" xml_f="18642" txt_i="13139" txt_f="13141">22</offsets></xref><offsets xml_i="18649" xml_f="18766" txt_i="13141" txt_f="13258"> Also, there is evidence suggesting that ketamine interferes with nicotinic, muscarinic, and monoaminergic receptors.</offsets></p><p><offsets xml_i="18773" xml_f="18978" txt_i="13259" txt_f="13464">As a result of the undesirable and unwanted side effects, ketamine usage is controversial in nonanesthetized patients, but when surgery is done under general anesthesia, these side effects are barely seen.</offsets><xref rid="b19-jpr-9-503" ref-type="bibr"><offsets xml_i="19020" xml_f="19022" txt_i="13464" txt_f="13466">19</offsets></xref><offsets xml_i="19029" xml_f="19175" txt_i="13466" txt_f="13612"> In this study, surgery was performed under general anesthesia and none of the patients experienced delirium and nightmare. In our previous study,</offsets><xref rid="b8-jpr-9-503" ref-type="bibr"><offsets xml_i="19216" xml_f="19217" txt_i="13612" txt_f="13613">8</offsets></xref><offsets xml_i="19224" xml_f="19714" txt_i="13613" txt_f="14103"> the effect of prophylactic ketamine on myalgia after ECT in 50 patients with major depression was demonstrated, in which 1 mg/kg of propofol and 0.3 mg/kg of ketamine were used for the induction of anesthesia, and muscle relaxation was induced using 0.5 mg/kg of succinylcholine. The results showed that the addition of ketamine to propofol had no effect on the incidence of myalgia after ECT, and only 12% of the patients had myalgia within 24 hours after ECT. However, our previous study</offsets><xref rid="b8-jpr-9-503" ref-type="bibr"><offsets xml_i="19755" xml_f="19756" txt_i="14103" txt_f="14104">8</offsets></xref><offsets xml_i="19763" xml_f="20050" txt_i="14104" txt_f="14391"> is different in some aspects from the present study. In our previous study, ECT patients were investigated and the cause of myalgia was found to be different in surgical patients. Second, unlike the surgery, myalgia intensity in ECT is not related to fasciculation and motor activities.</offsets><xref rid="b23-jpr-9-503" ref-type="bibr"><offsets xml_i="20092" xml_f="20094" txt_i="14391" txt_f="14393">23</offsets></xref><offsets xml_i="20101" xml_f="20355" txt_i="14393" txt_f="14647"> Third, the dose of anesthetic drugs for the induction of anesthesia and muscle relaxation was less than that of the present study. The result of our previous study, which was carried out on patients undergoing ECT, is not in line with the present study.</offsets></p><p><offsets xml_i="20362" xml_f="21194" txt_i="14648" txt_f="15480">Cardiovascular changes were similar after the induction of anesthesia in both groups. In theory, hemodynamic stability can be predicted based on the induction of anesthesia with propofol and ketamine, when compared with propofol alone. This is because ketamine increases blood pressure and heart rate; therefore, the addition of this drug to propofol during anesthesia induction can inhibit the reduction of these parameters before the stimulation of laryngoscopy and tracheal intubation. Also, following laryngoscopy and tracheal intubation, the synergistic effect of these two drugs can increase the depth of anesthesia and result in smoother cardiovascular response to airway stimulation. It appears that 0.5 mg/kg of ketamine could not produce such an impact on the hemodynamic system, thereby resulting in a significant effect.</offsets></p></sec><sec><title><offsets xml_i="21216" xml_f="21233" txt_i="15482" txt_f="15499">Study limitations</offsets></title><p><offsets xml_i="21244" xml_f="21729" txt_i="15500" txt_f="15985">One of the limitations of this study is the insufficient time for myalgia evaluation (24 hours). Failure to assess the incidence and severity of fasciculation is another limitation of this study. In this study, ketamine was diluted with sterile water, although this is not a wrong practice, but further addition of water, as carried out in this study, could produce ketamine with concentration below the physiological osmotic pressure, which may interfere with the effects of ketamine.</offsets></p></sec><sec><title><offsets xml_i="21751" xml_f="21761" txt_i="15987" txt_f="15997">Conclusion</offsets></title><p><offsets xml_i="21772" xml_f="21947" txt_i="15998" txt_f="16173">The addition of 0.5 mg/kg of ketamine to propofol for the induction of anesthesia can be effective in reducing the incidence of POM, without any change in hemodynamic indices.</offsets></p></sec></body><back><ack><title>Acknowledgments</title><p>This article has been extracted from general medicine thesis of Doctor Sanaz Arvin. The authors appreciate the Medical Faculty Research Council for approval and support of the project. We would like to gratefully and sincerely thank Doctor Faiegh Youssefi, who helped us with statistical analysis of results.</p></ack><fn-group><fn><p><bold>Author contributions</bold></p><p>KN and SA participated in the research design, data gathering, data analysis, and writing and finalizing the manuscript.</p></fn><fn><p><bold>Disclosure</bold></p><p>The authors report no conflicts of interest in this work.</p></fn></fn-group><ref-list><title>References</title><ref id="b1-jpr-9-503"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nasseri</surname><given-names>K</given-names></name><name><surname>Arasteh</surname><given-names>MT</given-names></name><name><surname>Afkhamzadeh</surname><given-names>A</given-names></name><name><surname>Hakhamaneshi</surname><given-names>S</given-names></name></person-group><article-title>Evaluation of prophylactic effect of remifentanil on succinylcholine-induced myalgia in humans</article-title><source>TJPR</source><year>2014</year><volume>13</volume><fpage>2027</fpage><lpage>2030</lpage></element-citation></ref><ref id="b2-jpr-9-503"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Karanovi</surname><given-names>N</given-names></name><name><surname>Carev</surname><given-names>M</given-names></name><name><surname>Kardum</surname><given-names>G</given-names></name><etal></etal></person-group><article-title>Succinylcholine use in adult anesthesia –A multinational questionnaire survey</article-title><source>Coll Antropol</source><year>2011</year><volume>35</volume><issue>Suppl 1</issue><fpage>183</fpage><lpage>190</lpage></element-citation></ref><ref id="b3-jpr-9-503"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pandey</surname><given-names>CK</given-names></name><name><surname>Tripathi</surname><given-names>M</given-names></name><name><surname>Joshi</surname><given-names>G</given-names></name><name><surname>Karna</surname><given-names>ST</given-names></name><name><surname>Singh</surname><given-names>N</given-names></name><name><surname>Singh</surname><given-names>PK</given-names></name></person-group><article-title>Prophylactic use of gabapentin for prevention of succinylcholine-induced fasciculation and myalgia: a randomized, double-blinded, placebo-controlled study</article-title><source>J Postgrad Med</source><year>2012</year><volume>58</volume><issue>1</issue><fpage>19</fpage><lpage>22</lpage><pub-id pub-id-type="pmid">22387644</pub-id></element-citation></ref><ref id="b4-jpr-9-503"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kararmaz</surname><given-names>A</given-names></name><name><surname>Kaya</surname><given-names>S</given-names></name><name><surname>Turhanoglu</surname><given-names>S</given-names></name><name><surname>Ozyilmaz</surname><given-names>MA</given-names></name></person-group><article-title>Effects of high-dose propofol on succinylcholine-induced fasciculations and myalgia</article-title><source>Acta Anaesthesiol Scand</source><year>2003</year><volume>47</volume><issue>2</issue><fpage>180</fpage><lpage>184</lpage><pub-id pub-id-type="pmid">12631047</pub-id></element-citation></ref><ref id="b5-jpr-9-503"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pandey</surname><given-names>CK</given-names></name><name><surname>Karna</surname><given-names>ST</given-names></name><name><surname>Tandon</surname><given-names>M</given-names></name><name><surname>Pandey</surname><given-names>VK</given-names></name><name><surname>Singh</surname><given-names>A</given-names></name></person-group><article-title>Comparative evaluation of prophylactic use of pregabalin, gabapentin and diclofenac sodium for prevention of succinylcholine-induced myalgia: a randomized, double-blinded study</article-title><source>J Postgrad Med</source><year>2014</year><volume>60</volume><issue>1</issue><fpage>16</fpage><lpage>20</lpage><pub-id pub-id-type="pmid">24625934</pub-id></element-citation></ref><ref id="b6-jpr-9-503"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kumar</surname><given-names>M</given-names></name><name><surname>Talwar</surname><given-names>N</given-names></name><name><surname>Goyal</surname><given-names>R</given-names></name><name><surname>Shukla</surname><given-names>U</given-names></name><name><surname>Sethi</surname><given-names>A</given-names></name></person-group><article-title>Effect of magnesium sulfate with propofol induction of anesthesia on succinylcholine-induced fasciculations and myalgia</article-title><source>J Anaesthesiol Clin Pharmacol</source><year>2012</year><volume>28</volume><issue>1</issue><fpage>81</fpage><lpage>85</lpage><pub-id pub-id-type="pmid">22345952</pub-id></element-citation></ref><ref id="b7-jpr-9-503"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kaur</surname><given-names>S</given-names></name><name><surname>Saroa</surname><given-names>R</given-names></name><name><surname>Aggarwal</surname><given-names>S</given-names></name></person-group><article-title>Effect of intraoperative infusion of low-dose ketamine on management of postoperative analgesia</article-title><source>J Nat Sc Biol Med</source><year>2015</year><volume>6</volume><issue>2</issue><fpage>378</fpage><lpage>382</lpage><pub-id pub-id-type="pmid">26283834</pub-id></element-citation></ref><ref id="b8-jpr-9-503"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nasseri</surname><given-names>K</given-names></name><name><surname>Shahsawari</surname><given-names>S</given-names></name><name><surname>Ziaee</surname><given-names>Z</given-names></name></person-group><article-title>Comparing the effects of propofol-ketamine to propofol-saline on myalgia post electroconvulsive therapy</article-title><source>J Mazandaran Univ Med Sci</source><year>2013</year><volume>23</volume><fpage>35</fpage><lpage>40</lpage></element-citation></ref><ref id="b9-jpr-9-503"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Smith</surname><given-names>I</given-names></name><name><surname>Ding</surname><given-names>Y</given-names></name><name><surname>White</surname><given-names>PF</given-names></name></person-group><article-title>Muscle pain after outpatient laparoscopy – influence of propofol versus thiopental and enflurane</article-title><source>Anesth Analg</source><year>1993</year><volume>76</volume><issue>6</issue><fpage>1181</fpage><lpage>1184</lpage><pub-id pub-id-type="pmid">8498652</pub-id></element-citation></ref><ref id="b10-jpr-9-503"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Newnam</surname><given-names>PT</given-names></name><name><surname>Loudon</surname><given-names>JM</given-names></name></person-group><article-title>Muscle pain following administration of suxamethonium: the aetiological role of muscular fitness</article-title><source>Br J Anaesth</source><year>1966</year><volume>38</volume><issue>7</issue><fpage>533</fpage><lpage>540</lpage><pub-id pub-id-type="pmid">5943809</pub-id></element-citation></ref><ref id="b11-jpr-9-503"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>KN</given-names></name><name><surname>Kim</surname><given-names>KS</given-names></name><name><surname>Choi</surname><given-names>HI</given-names></name><name><surname>Jeong</surname><given-names>JS</given-names></name><name><surname>Lee</surname><given-names>HJ</given-names></name></person-group><article-title>Optimal precurarizing dose of rocuronium to decrease fasciculation and myalgia following succinylcholine administration</article-title><source>Korean J Anesthesiol</source><year>2014</year><volume>66</volume><issue>6</issue><fpage>451</fpage><lpage>456</lpage><pub-id pub-id-type="pmid">25006369</pub-id></element-citation></ref><ref id="b12-jpr-9-503"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Erkola</surname><given-names>O</given-names></name></person-group><article-title>Effects of precurarisation on suxamethonium-induced postoperative myalgia during the first trimester of pregnancy</article-title><source>Acta Anaesthesiol Scand</source><year>1990</year><volume>34</volume><issue>1</issue><fpage>63</fpage><lpage>67</lpage><pub-id pub-id-type="pmid">1968694</pub-id></element-citation></ref><ref id="b13-jpr-9-503"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jackson</surname><given-names>MJ</given-names></name><name><surname>Jones</surname><given-names>DA</given-names></name><name><surname>Edwards</surname><given-names>RH</given-names></name></person-group><article-title>Experimental skeletal muscle damage: the nature of the calcium-activated degenerative processes</article-title><source>Eur J Clin Invest</source><year>1984</year><volume>14</volume><issue>5</issue><fpage>369</fpage><lpage>374</lpage><pub-id pub-id-type="pmid">6437835</pub-id></element-citation></ref><ref id="b14-jpr-9-503"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schreiber</surname><given-names>J</given-names></name><name><surname>Lysakowski</surname><given-names>C</given-names></name><name><surname>Fuchs-Buder</surname><given-names>T</given-names></name><name><surname>Tramer</surname><given-names>MR</given-names></name></person-group><article-title>Prevention of succinylecholine-induced fasciculations and myalgia. A meta analysis of randomized trials</article-title><source>Anesthesiology</source><year>2005</year><volume>103</volume><issue>4</issue><fpage>877</fpage><lpage>884</lpage><pub-id pub-id-type="pmid">16192781</pub-id></element-citation></ref><ref id="b15-jpr-9-503"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Noppers</surname><given-names>I</given-names></name><name><surname>Niesters</surname><given-names>M</given-names></name><name><surname>Aarts</surname><given-names>L</given-names></name><name><surname>Smith</surname><given-names>T</given-names></name><name><surname>Sarton</surname><given-names>E</given-names></name><name><surname>Dahan</surname><given-names>A</given-names></name></person-group><article-title>Ketamine for the treatment of chronic non-cancer pain</article-title><source>Expert Opin Pharmacother</source><year>2010</year><volume>11</volume><issue>14</issue><fpage>2417</fpage><lpage>2429</lpage><pub-id pub-id-type="pmid">20828267</pub-id></element-citation></ref><ref id="b16-jpr-9-503"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dahan</surname><given-names>A</given-names></name><name><surname>Olofsen</surname><given-names>E</given-names></name><name><surname>Sigtermans</surname><given-names>M</given-names></name><etal></etal></person-group><article-title>Population pharmacokinetic-pharmacodynamic modeling of ketamine-induced pain relief of chronic pain</article-title><source>Eur J Pain</source><year>2011</year><volume>15</volume><issue>3</issue><fpage>258</fpage><lpage>267</lpage><pub-id pub-id-type="pmid">20638877</pub-id></element-citation></ref><ref id="b17-jpr-9-503"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Petrenko</surname><given-names>AB</given-names></name><name><surname>Yamakura</surname><given-names>T</given-names></name><name><surname>Baba</surname><given-names>H</given-names></name><name><surname>Shimoji</surname><given-names>K</given-names></name></person-group><article-title>The role of N-methyl-D-aspartate (NMDA) receptors in pain: a review</article-title><source>Anesth Analg</source><year>2003</year><volume>97</volume><issue>4</issue><fpage>1108</fpage><lpage>1116</lpage><pub-id pub-id-type="pmid">14500166</pub-id></element-citation></ref><ref id="b18-jpr-9-503"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Elia</surname><given-names>N</given-names></name><name><surname>Tramèr</surname><given-names>MR</given-names></name></person-group><article-title>Ketamine and postoperative pain – a quantitative systematic review of randomised trials</article-title><source>Pain</source><year>2005</year><volume>113</volume><issue>1–2</issue><fpage>61</fpage><lpage>70</lpage><pub-id pub-id-type="pmid">15621365</pub-id></element-citation></ref><ref id="b19-jpr-9-503"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carstensen</surname><given-names>M</given-names></name><name><surname>Møller</surname><given-names>AM</given-names></name></person-group><article-title>Adding ketamine to morphine for intravenous patient-controlled analgesia for acute postoperative pain: a qualitative review of randomized trials</article-title><source>Br J Anaesth</source><year>2010</year><volume>104</volume><issue>4</issue><fpage>401</fpage><lpage>406</lpage><pub-id pub-id-type="pmid">20207747</pub-id></element-citation></ref><ref id="b20-jpr-9-503"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sarton</surname><given-names>E</given-names></name><name><surname>Teppema</surname><given-names>LJ</given-names></name><name><surname>Olievier</surname><given-names>C</given-names></name><etal></etal></person-group><article-title>The involvement of the mu-opioid receptor in ketamine-induced respiratory depression and antinociception</article-title><source>Anesth Analg</source><year>2001</year><volume>93</volume><issue>6</issue><fpage>1495</fpage><lpage>1500</lpage><pub-id pub-id-type="pmid">11726430</pub-id></element-citation></ref><ref id="b21-jpr-9-503"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Koizuka</surname><given-names>S</given-names></name><name><surname>Obata</surname><given-names>H</given-names></name><name><surname>Sasaki</surname><given-names>M</given-names></name><name><surname>Saito</surname><given-names>S</given-names></name><name><surname>Goto</surname><given-names>F</given-names></name></person-group><article-title>Systemic ketamine inhibits hypersensitivity after surgery via descending inhibitory pathways in rats</article-title><source>Can J Anaesth</source><year>2005</year><volume>52</volume><issue>5</issue><fpage>498</fpage><lpage>505</lpage><pub-id pub-id-type="pmid">15872129</pub-id></element-citation></ref><ref id="b22-jpr-9-503"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>De Kock</surname><given-names>MF</given-names></name><name><surname>Lavand’homme</surname><given-names>PM</given-names></name></person-group><article-title>The clinical role of NMDA receptor antagonists for the treatment of postoperative pain</article-title><source>Best Pract Res Clin Anaesthesiol</source><year>2007</year><volume>21</volume><issue>1</issue><fpage>85</fpage><lpage>98</lpage><pub-id pub-id-type="pmid">17489221</pub-id></element-citation></ref><ref id="b23-jpr-9-503"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dinwiddie</surname><given-names>SH</given-names></name><name><surname>Huo</surname><given-names>D</given-names></name><name><surname>Gottlieb</surname><given-names>O</given-names></name></person-group><article-title>The course of myalgia and headache after electroconvulsive therapy</article-title><source>J ECT</source><year>2010</year><volume>26</volume><issue>2</issue><fpage>116</fpage><lpage>120</lpage><pub-id pub-id-type="pmid">19710619</pub-id></element-citation></ref></ref-list></back><floats-group><fig id="f1-jpr-9-503" position="float"><label>Figure 1</label><caption><p>Flow diagram.</p></caption><graphic xlink:href="jpr-9-503Fig1"></graphic></fig><table-wrap id="t1-jpr-9-503" position="float"><label>Table 1</label><caption><p>Patients’ demographic data and duration of surgery for the normal saline (5 mL of saline IV) and ketamine (0.5 mg/kg of ketamine IV) groups</p></caption><table frame="hsides" rules="groups"><thead><tr><th valign="top" align="left" rowspan="1" colspan="1"></th><th valign="top" align="left" rowspan="1" colspan="1">Ketamine, n=71</th><th valign="top" align="left" rowspan="1" colspan="1">Saline, n=72</th><th valign="top" align="left" rowspan="1" colspan="1"><italic>P</italic>-value</th></tr></thead><tbody><tr><td valign="top" align="left" rowspan="1" colspan="1">Age, years</td><td valign="top" align="left" rowspan="1" colspan="1">39.2±2.6</td><td valign="top" align="left" rowspan="1" colspan="1">41.4±2.5</td><td valign="top" align="left" rowspan="1" colspan="1">0.9</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Sex (male/female)</td><td valign="top" align="left" rowspan="1" colspan="1">39/33</td><td valign="top" align="left" rowspan="1" colspan="1">41/31</td><td valign="top" align="left" rowspan="1" colspan="1">0.9</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Weight, kg</td><td valign="top" align="left" rowspan="1" colspan="1">69.8±3.8</td><td valign="top" align="left" rowspan="1" colspan="1">71.8±3.2</td><td valign="top" align="left" rowspan="1" colspan="1">0.6</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Duration of surgery</td><td valign="top" align="left" rowspan="1" colspan="1">27.5±26</td><td valign="top" align="left" rowspan="1" colspan="1">31±18</td><td valign="top" align="left" rowspan="1" colspan="1">0.7</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Type of surgery ENT/breast/abdomen/upper extremity</td><td valign="top" align="left" rowspan="1" colspan="1">14/9/36/12</td><td valign="top" align="left" rowspan="1" colspan="1">11/13/38/10</td><td valign="top" align="left" rowspan="1" colspan="1">0.9</td></tr></tbody></table><table-wrap-foot><fn id="tfn1-jpr-9-503"><p><bold>Note:</bold> Data are presented either as n or mean ± standard deviation.</p></fn><fn id="tfn2-jpr-9-503"><p><bold>Abbreviations:</bold> IV, intravenously; ENT, ear–nose–throat.</p></fn></table-wrap-foot></table-wrap><table-wrap id="t2-jpr-9-503" position="float"><label>Table 2</label><caption><p>Incidence and grade of myalgia in the normal saline (5 mL of saline IV) and ketamine (0.5 mg/kg of ketamine IV) groups</p></caption><table frame="hsides" rules="groups"><thead><tr><th valign="top" align="left" rowspan="1" colspan="1"></th><th valign="top" align="left" rowspan="1" colspan="1">Ketamine, n=71</th><th valign="top" align="left" rowspan="1" colspan="1">Saline, n=72</th><th valign="top" align="left" rowspan="1" colspan="1"><italic>P</italic>-value</th></tr></thead><tbody><tr><td valign="top" align="left" rowspan="1" colspan="1">Incidence, number (%)</td><td valign="top" align="left" rowspan="1" colspan="1">13 (18.1)</td><td valign="top" align="left" rowspan="1" colspan="1">36 (50)</td><td valign="top" align="left" rowspan="1" colspan="1">0.001</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Grade</td><td valign="top" align="left" rowspan="1" colspan="1"></td><td valign="top" align="left" rowspan="1" colspan="1"></td><td valign="top" align="left" rowspan="1" colspan="1"></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">0</td><td valign="top" align="left" rowspan="1" colspan="1">59 (81.9)</td><td valign="top" align="left" rowspan="1" colspan="1">36 (50)</td><td valign="top" align="left" rowspan="1" colspan="1">0.001</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">1</td><td valign="top" align="left" rowspan="1" colspan="1">9 (12.5)</td><td valign="top" align="left" rowspan="1" colspan="1">33 (45.8)</td><td valign="top" align="left" rowspan="1" colspan="1">0.001</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">2</td><td valign="top" align="left" rowspan="1" colspan="1">4 (5.6)</td><td valign="top" align="left" rowspan="1" colspan="1">3 (4.2)</td><td valign="top" align="left" rowspan="1" colspan="1">0.9</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">3</td><td valign="top" align="left" rowspan="1" colspan="1">0</td><td valign="top" align="left" rowspan="1" colspan="1">0</td><td valign="top" align="left" rowspan="1" colspan="1"></td></tr></tbody></table><table-wrap-foot><fn id="tfn3-jpr-9-503"><p><bold>Abbreviation:</bold> IV, intravenously.</p></fn></table-wrap-foot></table-wrap><table-wrap id="t3-jpr-9-503" position="float"><label>Table 3</label><caption><p>Cardiovascular parameters in the normal saline (5 mL of saline IV) and ketamine (0.5 mg/kg of ketamine IV) groups</p></caption><table frame="hsides" rules="groups"><thead><tr><th valign="top" align="left" rowspan="1" colspan="1"></th><th valign="top" align="left" rowspan="1" colspan="1">Ketamine, n=71</th><th valign="top" align="left" rowspan="1" colspan="1">Saline, n=72</th><th valign="top" align="left" rowspan="1" colspan="1"><italic>P</italic>-value</th></tr></thead><tbody><tr><td valign="top" align="left" rowspan="1" colspan="1">Systolic blood pressure</td><td valign="top" align="left" rowspan="1" colspan="1"></td><td valign="top" align="left" rowspan="1" colspan="1"></td><td valign="top" align="left" rowspan="1" colspan="1"></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Base</td><td valign="top" align="left" rowspan="1" colspan="1">139±20</td><td valign="top" align="left" rowspan="1" colspan="1">132±10</td><td valign="top" align="left" rowspan="1" colspan="1">0.55</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">After anesthesia induction</td><td valign="top" align="left" rowspan="1" colspan="1">118±13</td><td valign="top" align="left" rowspan="1" colspan="1">111±14</td><td valign="top" align="left" rowspan="1" colspan="1">0.04</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">5 minutes after intubation</td><td valign="top" align="left" rowspan="1" colspan="1">117±15</td><td valign="top" align="left" rowspan="1" colspan="1">115±23</td><td valign="top" align="left" rowspan="1" colspan="1">0.55</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Diastolic blood pressure</td><td valign="top" align="left" rowspan="1" colspan="1"></td><td valign="top" align="left" rowspan="1" colspan="1"></td><td valign="top" align="left" rowspan="1" colspan="1"></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Base</td><td valign="top" align="left" rowspan="1" colspan="1">81±12</td><td valign="top" align="left" rowspan="1" colspan="1">82±13</td><td valign="top" align="left" rowspan="1" colspan="1">0.51</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">After anesthesia induction</td><td valign="top" align="left" rowspan="1" colspan="1">73±11</td><td valign="top" align="left" rowspan="1" colspan="1">68±12</td><td valign="top" align="left" rowspan="1" colspan="1">0.01</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">5 minutes after intubation</td><td valign="top" align="left" rowspan="1" colspan="1">72±12</td><td valign="top" align="left" rowspan="1" colspan="1">71±13</td><td valign="top" align="left" rowspan="1" colspan="1">0.51</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Heart rate</td><td valign="top" align="left" rowspan="1" colspan="1"></td><td valign="top" align="left" rowspan="1" colspan="1"></td><td valign="top" align="left" rowspan="1" colspan="1"></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Base</td><td valign="top" align="left" rowspan="1" colspan="1">89±15</td><td valign="top" align="left" rowspan="1" colspan="1">88±17</td><td valign="top" align="left" rowspan="1" colspan="1">0.57</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">After anesthesia induction</td><td valign="top" align="left" rowspan="1" colspan="1">82±20</td><td valign="top" align="left" rowspan="1" colspan="1">78±15</td><td valign="top" align="left" rowspan="1" colspan="1">0.04</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">5 minutes after intubation</td><td valign="top" align="left" rowspan="1" colspan="1">81±20</td><td valign="top" align="left" rowspan="1" colspan="1">88±15</td><td valign="top" align="left" rowspan="1" colspan="1">0.06</td></tr></tbody></table><table-wrap-foot><fn id="tfn4-jpr-9-503"><p><bold>Note:</bold> Data are presented as mean ± standard deviation.</p></fn><fn id="tfn5-jpr-9-503"><p><bold>Abbreviation:</bold> IV, intravenously.</p></fn></table-wrap-foot></table-wrap></floats-group></article>